Leadership

Dear Friends,

“Someday, they will find a way.” When it comes to discovery and science that drives medical breakthroughs, “they” are here at LA BioMed and “someday” is today.

LA BioMed had a very successful 2012.

• We opened two new research buildings, the Children’s Health Research Center and Chronic Diseases Clinical Research Center, adding 32,000 square feet of modern laboratory space. These state-of-the-art facilities now house six major research groups and position us for even greater successes in the upcoming years.

• We bolstered our programs in cancer, cerebrovascular diseases, stem cell therapy, juvenile obesity, reproductive health, and COPD by recruiting seven experts in medical genetics, endocrinology, and exercise rehabilitation therapy.

• We formed two spin-off companies to accelerate promising therapeutic approaches to schizophrenia and antibiotic-resistant infection.

• We launched more than 50 research projects that could one day lead to life-saving breakthroughs for patients. More than a dozen LA BioMed investigators were awarded prestigious peer-reviewed grants from federal scientific funding agencies to undertake these projects.

Medical advances don’t just happen.  They occur because of the collaboration of many stakeholders and over the past six decades, LA BioMed has been responsible for some of the most critical advancements in medical science.

Best regards,

Board or Directors

Officers:

Steven A. Nissen, Esq., Chair
Ronald S. Swerdloff, M.D., Vice Chair
Richard K. Learned, Treasurer
Eric S. Daar, M.D., Secretary
David I. Meyer, Ph.D., President/CEO

Directors: